PhenoMx: The Personalized Digital Physical Exam

by Parth Agrawal

PhenoMx has developed a personalized Digital Physical Exam to assess the major vital organs and tissues from a whole body perspective for improved health and longevity.
New York, United States Fitness or Wellness Healthy Living AI in Medicine

All Team Company Physicians Hospital Partners Mission Innovation Details Supporters Comments Updates

About our project

The problem we solve:
Healthcare/medicine is practiced in reaction to a recent injury or presentation of a longer term condition or disease. Today imaging is used after a Physical Exam by a physician, as a confirmation of initial findings. Imaging is only applied to a very specific anatomy or area of interest based on a potential diagnosis.
About our solution:
Personalized digital physical exam to help predict disease risks, by directly assessing the vital organs & tissues from a whole body perspective,utilizing: non-invasive medical imaging to acquire data,automation algorithms to quantify images, and Artificial Intelligence to develop predictive analytics for improved health. SAAS platform enables access to the latest imaging technology, and support for legacy scanners,while improving accuracy,precision,and standardization across imaging facilities.
Progress to date:
  1. Protocols are complete & ready to be installed on client scanners, while cloud analytics platform is ready to perform processing & provide deliverables/reports.

  2. Platform comprised of different backend processing techniques. Client facing screens are for cloud based data uploading of imaging data. Library of disease focused risk prediction models under development & will grow with each scan prospective scan that is acquired and processed, along with any retrospective datasets that are analyzed.


About Our Team


Creator: Parth Agrawal
Location: Indiana
Bio: Parth is a Biomedical Engineer who has been trained in Project Management and Product Development. He is interested in the Healthcare applications of Deep Learning. He is well travelled and in his spare time loves to play Squash.
Title: Business Development
Advanced Degree(s): MS in Biomedical Technology, Master of Biomedical Innovation and Development

About Team Members

Mark Punyanitya
CEO, Vanderbilt University-Biomedical Engineering Columbia University-Master’s Applied Physiology New York University-Master’s Applied Clinical Trials
Biography: Imaging Expert – 15+ yrs of domain expertise in global multi-center clinical trials utilizing quantitative imaging. Founder of Image Reading Center, Inc. (an active Imaging Core Lab and Contract Research Organization)
Title: CEO
Advanced Degree(s): Vanderbilt University-Biomedical Engineering Columbia University-Master’s Applied Physiology New York University-Master’s Applied Clinical Trials
Twitter: @markpun
LinkedIn: https://www.linkedin.com/in/markpun/

Zachary Rapp
COO, Columbia University-Master’s in Biotechnology & Entrepreneurship University of California, Berkeley, School of Law-Certificate 500 Startups VC Unlocked: Venture Capital & Early-Stage Investing Drew University-BA in Biological Anthropology
Biography: Entrepreneur, consultant, and advisor driven to architect and invest in disruptive patient-centric & science-driven ventures. 5+ yrs in oncology and genetics drug discovery and development research.Co- founded and licensed out enzyme replacement therapy to small-cap biopharma company. Advises select life science companies, and has successfully assisted in raising capital for early-stage ventures.
Title: COO
Advanced Degree(s): Columbia University-Master’s in Biotechnology & Entrepreneurship University of California, Berkeley, School of Law-Certificate 500 Startups VC Unlocked: Venture Capital & Early-Stage Investing Drew University-BA in Biological Anthropology
Twitter: @zachary_rapp
LinkedIn: https://www.linkedin.com/in/zacharyrapp/

Girish Srinivasan
CTO, University of Madras-Bachelor’s Degree Computer Engineering University at Buffalo-Master’s Degree Computer Science University of Illinois at Chicago-Doctor of Philosophy (Ph.D.) Bio Engineering, Medical Imaging
Biography: 13+ years Healthcare Solutions Leader, Clinical Research & Diagnostic Applications & Platform. Former Samsung, GE, Toshiba.
Title: CTO
Advanced Degree(s): University of Madras-Bachelor’s Degree Computer Engineering University at Buffalo-Master’s Degree Computer Science University of Illinois at Chicago-Doctor of Philosophy (Ph.D.) Bio Engineering, Medical Imaging
Twitter: @girisriniv1
LinkedIn: https://www.linkedin.com/in/srinivasangirish

Andrew Bogle
Co-Founder, Vanderbilt University-MBA in Finance Connecticut College-BA in Economics
Biography: Active advisor and angel investor. Creating an angel fund among friends. Since 2010, has spent significant time with entrepreneurs connecting them to other entrepreneurs, angel investors, advisors and potential clients of their business. Serves on two non-proitt Boards and several corporate Advisory Boards.
Title: Co-Founder
Advanced Degree(s): Vanderbilt University-MBA in Finance Connecticut College-BA in Economics
Twitter: @andrewbogle
LinkedIn: https://www.linkedin.com/in/andrew-bogle-5b0641

About Our Company

PhenoMx
Location: 105 East 34th Street #148 New York NY
New York 10016
Website: http://www.phenomx.co
Product Stage: Ready
YTD Sales: Working on it
Employees: 5-10

How We Help Physicians

Personalized digital physical exam to help predict disease risks, by directly assessing the vital organs & tissues from a whole body perspective,utilizing: non-invasive medical imaging to acquire data,automation algorithms to quantify images, and Artificial Intelligence to develop predictive analytics for improved health.

SAAS platform enables access to the latest imaging technology, and support for legacy scanners,while improving accuracy,precision,and standardization across imaging facilities.


How We Help Hospitals

  1. Healthcare/medicine is practiced in reaction to a recent injury or presentation of a longer term condition or disease.

  2. Imaging is currently used after a Physical Exam by a physician, as a confirmation of initial findings. Imaging is only applied to a very specific anatomy or area of interest based on a potential diagnosis.

  3. With over 20 years of experience managing global multicenter clinical trials for academic, biotech, pharma companies, we have overseen the evaluation/selection, installation/training, acquisition/quality control, and conduct/outcomes, of quantitative imaging technologies.

  4. Majority of healthcare solutions fall under a reactive model by providing a diagnosis and then treatment. To solve the problem of diagnosing a patient after the onset of a medical condition requires an earlier stage of intervention to better treat, reverse, or inhibit a disease. In order to achieve this, solutions need to exist in a proactive model that identify, measure, and monitor applicable biomarkers that give patients a window of opportunity to prevent disease prior to biological onset.


How We Help Partners

For Investors

We are addressing a combined market of $256B

b) these markets include the latest technical advances that are changing the future of healthcare and medicine

c) Combined market of $256B comprised of:

BIOMARKERS $97B (2020)

PRECISION MEDICINE $87B (2023)

MEDICAL IMAGING $46B (2022)

HEALTHCARE ANALYTICS $19B (2020)

MRI SYSTEMS $7B (2020)


Challenge Mission

Key Milestones Achieved and Planned

By end of Q1 2018 we would have done the following-

  • Secured additional technology licenses and strategic partners
  • Initiated pilot/validation study with key opinion leader/institution

  • Secured initial client/customer (either biotech/pharma/CRO or health/wellness facility)

  • Further development of platform

We plan to do the following starting in Q3 2018

  • Completion of retrospective study
  • Publication of clinical study validation

  • Submission of regulatory application

  • Strategic partnerships with pre-release partners



Our Competitive Advantages
  1. Competitive Advantage- Unique technical expertise in installing & managing advanced imaging technologies to provide a quantitative approach that delivers insights from combined organ & tissue interaction. Unique market insight from experience/expertise evaluating imaging techniques and training hundreds of imaging facilities.

  2. Novelty of technology- Typical imaging companies develop individual techniques that only focus on a single organ or tissue, while we are focused on providing a comprehensive solution beyond what any one single provider could offer.

  3. No new stake holders.



Barriers to Entry

We currently hold an exclusive, worldwide, all domains of practice license for an algorithm to map scar tissue in the heart. We will be developing new IP based off of this core technology, as well as the integration of the different imaging technologies that we are and will be working with.



Traction, Funding and Partners

Current customer is IPMC in South Korea. 3 projects: 100 participants over a period of 1 year, offered for the residents of Paju city, supported by the Korean government.

Project 2: offer annual digital physical examination to employees of 2 large corporate customers

Project 3: Alzheimer’s moonshot project to diagnose, treat and prevent the occurrence of mental disorders

We are on discussions with replicating similar services for precision medicine in China, Middle East, US and Europe.

Innovation Details

Intellectual Property Summary

We currently hold an exclusive, worldwide, all domains of practice license for an algorithm to map scar tissue in the heart. We will be developing new IP based off of this core technology, as well as the integration of the different imaging technologies that we are and will be working with.

Clinical Information

Current customer is IPMC in South Korea. 3 projects: 100 participants over a period of 1 year, offered for the residents of Paju city, supported by the Korean government.

Project 2: offer annual digital physical examination to employees of 2 large corporate customers

Project 3: Alzheimer’s moonshot project to diagnose, treat and prevent the occurrence of mental disorders

We are on discussions with replicating similar services for precision medicine in China, Middle East, US and Europe.

Regulatory Status

No need for FDA clearance.

How we will use the funds raised

Product Development

Marketing

Operational Expenses

Thank You

PhenoMx was conceived by a group of accomplished industry veterans with experience managing the entire lifecycle of diagnostic image solutions, from early clinical to product management to end user. Our focus is advancing high value imaging of the whole body.

 

PhenoMx, enables innovators to enter, navigate, and grow related technology in the diagnostic imaging space through commercial partnership, licensing agreement, and subsidy arrangements.

 

Our team of industry veterans have amassed a significant amount of unique experiences and relationships that not only provide deep domain expertise in this specific market, but also allows for insight into upcoming trends in the R&D space, so that we are able to make valuable assessments of which technologies are appropriate for commercialization and further development in existing and new markets that we are creating.

Supporters

Comments

Login to post your comment!
Click here to Login

Updates

    No updates found .

$ 0

pledged of $ 250,000 goal

  • 88 Days left

21

Interest
Score

0

Adoption
Score

Parth Agrawal
Business Development

Proflle
Contact Me


Rewards All contributions are tax-deductible.